Ben Forbes

Professor of Pharmaceutics

King's College London - Waterloo Campus

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Drug Delivery Drug Delivery professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (14)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (6)

Anthony David Edwards

King’s College London

UNITED KINGDOM

View details

Bahijja Raimi-Abraham

King’s College London

UNITED KINGDOM

View details

Suresh Victor

King’s College London

UNITED KINGDOM

View details

Ka Lung Andrew Chan

King’s College London

UNITED KINGDOM

View details

Karolin Hijazi

Professor and Honorary Consultant in Oral Medicine

University of Aberdeen

UNITED KINGDOM

View details

Simon Pitchford

King’s College London

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ben Forbes

Research Interests

Explore related searches

Contact this professor

Articles (14)

Manufacture and Initial Characterisation of RAPIDTM Biodynamic Haematogel, an Autologous Platelet and Leukocyte-Rich Plasma Gel for Diabetic Foot Ulcers

Pullulan-Based Spray-Dried Mucoadhesive Microparticles for Sustained Oromucosal Drug Delivery

iBCS: 3. A Biopharmaceutics Classification System for Orally Inhaled Drug Products

The importance of dissolution for orally inhaled drug products: pharmaceutical, regulatory, and clinical considerations

PPAR Gamma Receptor: A Novel Target to Improve Morbidity in Preterm Babies

Characterizing RAPIDTM platelet and leukocyte-rich plasma gels – an autologous, point-of-care medicine for diabetic foot ulcer treatment.

Comprehensive Study of Antiretroviral Drug Permeability at the Cervicovaginal Mucosa <i>via</i> an In Vitro Model

iBCS: 1. Principles and Framework of an Inhalation-Based Biopharmaceutics Classification System

iBCS: 2. Mechanistic Modeling of Pulmonary Availability of Inhaled Drugs versus Critical Product Attributes

Exploiting Endocytosis for Non-Spherical Nanoparticle Cellular Uptake

RespiCellTM: An Innovative Dissolution Apparatus for Inhaled Products

Improving Drug Delivery for Alzheimer’s Disease Through Nose-to-Brain Delivery Using Nanoemulsions, Nanostructured Lipid Carriers (NLC) and in situ Hydrogels

Drug metabolism in the lungs: opportunities for optimising inhaled medicines

In vitro and in vivo antitubercular activity of benzothiazinone-loaded human serum albumin nanocarriers designed for inhalation

Collaborators (6)

Anthony David Edwards

Bahijja Raimi-Abraham

Suresh Victor

Ka Lung Andrew Chan

Karolin Hijazi

Simon Pitchford

Make your next move.